Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

10.0%

1 terminated out of 10 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed with results

Key Signals

2 with results83% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (1)
P 1 (1)
P 2 (3)
P 4 (2)

Trial Status

Completed5
Not Yet Recruiting2
Active Not Recruiting1
Terminated1
Unknown1

Trial Success Rate

83.3%

Benchmark: 86.6%

Based on 5 completed trials

Clinical Trials (10)

Showing 10 of 10 trials
Showing all 10 trials

Research Network

Activity Timeline